---
title: "Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bott... — FDA record D-0088-2024 | Is It on Recall"
description: "Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 2"
url: https://isitonrecall.com/recall/fda-drug-d-0088-2024-synthroid-levothyroxine-sodium-tablets-usp-125mcg-0-125mg-100-count-bottle-rx-only-abbvie-inc-north/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, I... — FDA record D-0088-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Oct 17, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11
- **Reason**: Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
- **Classification**: Class III
- **Recalling firm**: AbbVie Inc.
- **Quantity**: 864 cartons
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0088-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0088-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # 1187435 exp date: 02/2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Distributed in the US. No government or foreign consignees.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Report date**: Nov 15, 2023
- **Recall initiation date**: Oct 17, 2023
- **Center classification date**: Nov 5, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0088-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Levothyroxine records](https://isitonrecall.com/drug/levothyroxine/) [Medications records](https://isitonrecall.com/category/medications/) [AbbVie Inc. records](https://isitonrecall.com/brand/abbvie-inc/)